Search results for "heart disease"

showing 10 items of 489 documents

LDL size: does it matter?

2004

The atherogenic lipoprotein phenotype is characterised by a moderate increase in plasma triglycerides, a decrease in high density lipoprotein cholesterol and the prevalence of smaller denser low density lipoprotein particles. The prevalence of this partially inheritable phenotype is approximately 30% and is a feature of the metabolic syndrome associated with an increased risk for cardiovascular events. The predominance of small dense LDL has been accepted as an emerging cardiovascular risk factor by the adult treatment panel (ATP) III.

AdultMalemedicine.medical_specialtyArteriosclerosisCoronary DiseaseCohort Studieschemistry.chemical_compoundHigh-density lipoproteinSex FactorsRisk FactorsInternal medicineDiabetes mellitusmedicineDiabetes MellitusPrevalenceAnimalsHumansatherogenic lipoprotein phenotypeProspective Studiescoronary heart diseaseRisk factorsmall dense LDLTriglyceridesAgedHypolipidemic AgentsMetabolic SyndromeClinical Trials as Topicdiabetesbusiness.industryCholesterolSmokingAge FactorsGeneral MedicineCholesterol LDLAtherogenic lipoprotein phenotypeMiddle Agedmedicine.diseasePhenotypeLipoproteins LDLEndocrinologyLogistic ModelsPhenotypechemistryLow-density lipoproteinFemaleMetabolic syndromeInsulin ResistancebusinessSwiss medical weekly
researchProduct

Haemodynamic effects of a single intravenous dose of lorcainide in patients with heart disease

1980

The cardiovascular effects of a single i.v. dose (2 mg/kg over 5 min) of lorcainide were studied in 14 patients with heart disease. In the haemodynamic part of the study (6 patients), the aortic and pulmonary systolic, diastolic and mean pressures, left ventricular systolic and end-diastolic pressures, cardiac output and the rate of rise of left ventricular pressure were measured before and for 30 min after administration of the drug. Lorcainide produced a slight and short-lasting decrease in the aortic and pulmonary systolic pressures, and all other pressure values remained unchanged. The cardiac output and systemic vascular resistance were not altered by lorcainide. It consistently depres…

AdultMalemedicine.medical_specialtyCardiac outputTime FactorsHeart DiseasesHeart diseaseBenzeneacetamidesDiastoleHemodynamicsBlood PressureLorcainidePiperidinesInternal medicinemedicineHumansPharmacology (medical)Cardiac OutputAgedPharmacologyEjection fractionbusiness.industryHeartGeneral MedicineMiddle Agedmedicine.diseaseMyocardial Contractionmedicine.anatomical_structureAnesthesiaVascular resistanceVentricular pressureCardiologyFemaleVascular ResistancebusinessAnti-Arrhythmia Agentsmedicine.drugEuropean Journal of Clinical Pharmacology
researchProduct

Long-Term Enoximone Therapy in Unstable Chronic Heart Failure

1989

Long-term safety and efficacy of oral enoximone were evaluated in 32 patients with unstable chronic heart failure despite digitalis, diuretics, and vasodilator therapy. Oral enoximone, 75-150 mg t.i.d. was given for an average of 32 weeks. At baseline, 21 patients were in NYHA functional class IV, 10 patients in class III, and 1 patient in class II. Within 12 weeks, 14 of 20 patients surviving for more than 26 weeks had improved by at least one functional class. Hemodynamic data showed an 18% increase of cardiac index and a 34% decrease of diastolic pulmonary artery pressure. Echocardiographic recordings revealed an increase of fractional shortening from 13.9 +/- 7 to 15.6 +/- 5% after 12 w…

AdultMalemedicine.medical_specialtyCardiotonic AgentsHeart diseaseCardiac indexDiastoleSudden deathElectrocardiographyInternal medicinemedicine.arterymedicineHumansEnoximoneEnoximoneSurvival rateAgedAged 80 and overHeart FailurePharmacologybusiness.industryHemodynamicsImidazolesMiddle Agedmedicine.diseaseSurgeryHeart failureChronic DiseasePulmonary arteryCardiologyFemalebusinessCardiology and Cardiovascular Medicinemedicine.drugJournal of Cardiovascular Pharmacology
researchProduct

Left ventricular hypertrophy in chronic kidney disease: A diagnostic criteria comparison.

2020

Background and aims: CKD patients have a high prevalence of LVH and this leads to an increase of cardiovascular risk. The aim of this study was to assess the prevalence of left ventricular hypertrophy (LVH) and left ventricular geometry in a group of 293 hypertensive patients with stage 2–5 chronic kidney disease (CKD), compared with 289 essential hypertensive patients with normal renal function. Methods and results: All patients underwent echocardiographic examination. Patients on stage 1 CKD, dialysis treatment, or with cardiovascular diseases were excluded. LVH was observed in 62.8% of patients with CKD and in 51.9% of essential hypertensive patients (P < 0.0001). We found increasingl…

AdultMalemedicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentPopulationMedicine (miscellaneous)030209 endocrinology & metabolismBlood Pressure030204 cardiovascular system & hematologyurologic and male genital diseasesLeft ventricular hypertrophyRisk AssessmentVentricular Function Left03 medical and health sciencesNormal renal functionYoung Adult0302 clinical medicineInternal medicinePrevalenceMedicineHumansLeft ventricular geometryIn patientcardiovascular diseasesStage (cooking)Renal Insufficiency ChroniceducationDialysisAgededucation.field_of_studyNutrition and DieteticsVentricular Remodelingbusiness.industryMiddle Agedmedicine.diseaseCKD Echocardiography Hypertension Letf ventricular hypertrophy Ventricular geometryCross-Sectional StudiesItalyHeart Disease Risk FactorsHypertensionCardiologyFemaleHypertrophy Left VentricularEssential HypertensionCardiology and Cardiovascular MedicinebusinessKidney diseaseNutrition, metabolism, and cardiovascular diseases : NMCD
researchProduct

Insulin-like growth factor 1 and sodium-lithium countertransport in essential hypertension and in hypertensive left ventricular hypertrophy

1993

The aim of this work was to study the insulin-like growth factor 1 (IGF1), a substance able to promote cell proliferation in vascular smooth muscle, in patients with mild-to-moderate hypertension and to analyse its relationship to sodium-lithium countertransport, a genetic marker of hypertension that is related to cardiovascular complications.We studied 32 hypertensive subjects, some with left ventricular hypertrophy, and 14 healthy subjects. Fasting plasma IGF1 was measured by means of a radioimmunoassay after octadecylsilica chromatography and Na(+)-Li+ countertransport was determined by the method of Canessa.Hypertensive patients had higher values of both IGF1 and Na(+)-Li+ countertransp…

AdultMalemedicine.medical_specialtyErythrocytesVascular smooth muscleLithium (medication)Heart diseasePhysiologymedicine.medical_treatmentEssential hypertensionLeft ventricular hypertrophyAntiportersMuscle hypertrophyInsulin-like growth factorReference ValuesInternal medicineInternal MedicineHumansMedicineInsulin-Like Growth Factor Ibusiness.industryGrowth factorMiddle Agedmedicine.diseaseEndocrinologyHypertensionFemaleHypertrophy Left VentricularCardiology and Cardiovascular Medicinebusinessmedicine.drug
researchProduct

Gender Inequalities in Diagnostic Inertia around the Three Most Prevalent Cardiovascular Risk Studies: Protocol for a Population-Based Cohort Study

2021

Evidence shows that objectives for detecting and controlling cardiovascular risk factors are not being effectively met, and moreover, outcomes differ between men and women. This study will assess the gender-related differences in diagnostic inertia around the three most prevalent cardiovascular risk factors: dyslipidemia, arterial hypertension, and diabetes mellitus, and to evaluate the consequences on cardiovascular disease incidence. This is an epidemiological and cohort study. Eligible patients will be adults who presented to public primary health care centers in a Spanish region from 2008 to 2011, with hypertension, dyslipidemia, or/and diabetes and without cardiovascular disease. Parti…

AdultMalemedicine.medical_specialtyHealth Toxicology and Mutagenesislcsh:MedicineDisease030204 cardiovascular system & hematologyCohort Studies03 medical and health sciencesStudy Protocol0302 clinical medicineRisk FactorsEpidemiologyHealth caremedicineHumansrisk factors030212 general & internal medicinebusiness.industryPublic healthMedical recordlcsh:Rpublic healthPublic Health Environmental and Occupational Healthmedicine.diseasecardiovascular diseasessex factorsCross-Sectional Studiesdisease managementCardiovascular DiseasesHeart Disease Risk FactorsCohortEmergency medicineFemalebusinessDyslipidemiaCohort study
researchProduct

Distribution and categorization of left ventricular measurements in the general population: results from the population-based Gutenberg Heart Study.

2010

Background— Echocardiography, the dominant imaging modality for quantification of left ventricular metrics, has undergone continuing development in the past few decades. However, given the lack of population-based data, current guidelines are still based on restricted and small data sets analyzed with methods including expert opinion. This work presents empirically derived reference values from a large-scale, epidemiologic study conducted with state-of-the-art imaging technology and methods. Methods and Results— The distribution of echocardiographic measurements of the left ventricle was analyzed in a population-based sample of 5000 mid-Europeans from the Gutenberg Heart Study in Germany. …

AdultMalemedicine.medical_specialtyHeart DiseasesHeart VentriclesPopulationSample (statistics)Severity of Illness IndexVentricular Function LeftAge DistributionSex FactorsPredictive Value of TestsReference ValuesGermanyMedicineHumansRadiology Nuclear Medicine and imagingProspective StudiesSex DistributioneducationAgedUltrasonographyAged 80 and overeducation.field_of_studybusiness.industryAge FactorsNomogramMiddle AgedHealth SurveysQuantile regressionSurgeryData setNomogramsCategorizationPredictive value of testsImaging technologyFemaleCardiology and Cardiovascular MedicinebusinessCartographyCirculation. Cardiovascular imaging
researchProduct

In-hospital complications of acute myocardial infarction in hypertensive subjects

2005

Recent studies have shown a worse in-hospital outcome in hypertensive than in normotensive patients with acute myocardial infarction (AMI), which has been attributed to more frequent complications. The aim of this study was to investigate clinical patterns, risk factors, and in-hospital complications in hypertensive and normotensive patients with AMI.Of 4994 consecutive patients with AMI admitted to the intensive care unit, hypertensive patients with first infarction (n = 915; mean age 68.8 +/- 11.4 years) and 915 gender- and age-matched normotensive subjects were retrospectively studied.In the univariate analysis, hypertensive subjects presented more frequently non-Q-wave infarction and ST…

AdultMalemedicine.medical_specialtyHeart DiseasesMyocardial InfarctionInfarctionlaw.inventionElectrocardiographylawInternal medicineDiabetes mellitusInternal MedicinemedicineHumansST segmentcardiovascular diseasesMyocardial infarctionAntihypertensive AgentsAgedRetrospective StudiesAged 80 and overST depressionInpatientsUnivariate analysisbusiness.industryCoronary Care UnitsMiddle Agedmedicine.diseaseIntensive care unitCase-Control StudiesHypertensionCardiologyFemalemedicine.symptombusinessDyslipidemiaAmerican Journal of Hypertension
researchProduct

Linear and nonlinear heart rate dynamics in elderly inpatients. Relations with comorbidity and depression

2010

Background. Hospitalization processes are known to increase depressive symptoms arising among elderly population. Meanwhile, dysregulation of cardiac autonomic function has been suggested to link depression and cardiovascular mortality. In this context, analysis of heart rate variability (HRV) is emerging as a powerful mortality risk stratifier clinical tool. The purpose of the study was to examine the relationship among HRV, depression, and comorbidity risk among an elderly inpatient population. Material and methods. Twenty-six subjects (aged 78±9 years) were recruited from the Short- Term Stay Unit at the Hospital General de Alicante. Before joining a Physical Activity Program aimed to pr…

AdultMalemedicine.medical_specialtyHeart DiseasesPopulationContext (language use)Risk AssessmentelderlySampling StudiesinpatientsElectrocardiographySex FactorsHeart RateInternal medicineHeart ratePrevalencemedicineAnimalsHumansHeart rate variabilityeducationGeriatric AssessmentDepression (differential diagnoses)AgedAged 80 and overeducation.field_of_studybusiness.industryAge Factorsheart rate variabilityGeneral Medicinemedicine.diseaseComorbiditySample entropycomorbidityNonlinear DynamicsData Interpretation StatisticaldepressionPhysical therapyheart rate variability; comorbidity; depression; elderly; inpatientsFemaleGeriatric Depression ScalebusinessMedicina
researchProduct

Left ventricular volume determination using Albunex.

1996

The aim of this study was to assess the ability of intravenous injection of Albunex to improve left ventricular volume determination in patients with various cardiac diseases. It is conceivable that the intravenous injection of microbubbles could improve echocardiographic left ventricular border delineation leading to improved interobserver variability. Echocardiograms were obtained during simultaneous intravenous injection of 0.08 and 0.12 ml/kg Albunex (four-chamber view). Within 6 hours after the recording of the contrast echocardiograms routine left heart angiography was performed. Volumes were measured using the slice method in native and contrast echocardiograms as well as in the angi…

AdultMalemedicine.medical_specialtyHeart DiseasesSystoleCardiac VolumeHeart angiographyContrast MediaEnd systoleVentricular Function LeftDiastoleInternal medicineAlbuminsmedicineConfidence IntervalsHumansRadiology Nuclear Medicine and imagingIn patientEnd diastoleAgedObserver VariationEjection fractionbusiness.industryCineradiographyAngiocardiographyHeartStroke VolumeMiddle AgedConfidence intervalMicrospheresEchocardiographyInjections IntravenousCardiologyMicrobubblesVentricular volumeFemaleCardiology and Cardiovascular MedicinebusinessJournal of the American Society of Echocardiography : official publication of the American Society of Echocardiography
researchProduct